These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 18510525)
1. Relevance of quantitative assessment of bleeding in haemorrhagic disorders. Rodeghiero F; Kadir RA; Tosetto A; James PD Haemophilia; 2008 Jul; 14 Suppl 3():68-75. PubMed ID: 18510525 [TBL] [Abstract][Full Text] [Related]
2. Bleeding scores in inherited bleeding disorders: clinical or research tools? Tosetto A; Castaman G; Rodeghiero F Haemophilia; 2008 May; 14(3):415-22. PubMed ID: 18218013 [TBL] [Abstract][Full Text] [Related]
3. Assessing bleeding in von Willebrand disease with bleeding score. Tosetto A; Castaman G; Rodeghiero F Blood Rev; 2007 Mar; 21(2):89-97. PubMed ID: 16774804 [TBL] [Abstract][Full Text] [Related]
4. Bleeding symptom assessment and hemostasis evaluation of menorrhagia. Kouides PA Curr Opin Hematol; 2008 Sep; 15(5):465-72. PubMed ID: 18695369 [TBL] [Abstract][Full Text] [Related]
5. Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation. Philipp CS; Faiz A; Dowling NF; Beckman M; Owens S; Ayers C; Bachmann G Am J Obstet Gynecol; 2008 Feb; 198(2):163.e1-8. PubMed ID: 18226613 [TBL] [Abstract][Full Text] [Related]
6. [Von Willebrand disease: a common and unrecognized bleeding disorder]. Boehlen F; Robert-Ebadi H; de Moerloose P Rev Med Suisse; 2007 Feb; 3(97):346-50. PubMed ID: 17370733 [TBL] [Abstract][Full Text] [Related]
7. [Menorrhagia, hypermenorrhea and disorders of hemostasis]. Righini M; Gerber S; Hohlfeld P; de Moerloose P J Gynecol Obstet Biol Reprod (Paris); 1999 Sep; 28(5):413-8. PubMed ID: 10566159 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of abnormal bleeding in women. Kouides PA Curr Hematol Rep; 2002 Sep; 1(1):11-8. PubMed ID: 12901120 [TBL] [Abstract][Full Text] [Related]
9. The usefulness of the platelet function analyser (PFA-100) in screening for underlying bleeding disorders in women with menorrhagia. Acharya S; Barraclough J; Ibrahim MS; Oxby C; Jones SE; Parapia L; O'donovan P J Obstet Gynaecol; 2008 Apr; 28(3):310-4. PubMed ID: 18569475 [TBL] [Abstract][Full Text] [Related]
10. [Principal symptoms in hemostasis disorders]. Coninx S; Beck EA Schweiz Med Wochenschr; 1979 Feb; 109(5):137-41. PubMed ID: 312528 [TBL] [Abstract][Full Text] [Related]
11. Management of children with inherited mild bleeding disorders undergoing adenotonsillar procedures. García-Matte R; María Constanza Beltrán M; Ximena Fonseca A; Pamela Zúñiga C Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):291-4. PubMed ID: 22188821 [TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A; Berneman Z; Schroyens W; Michiels JJ Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359 [TBL] [Abstract][Full Text] [Related]
13. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible. Pereira J; Quiroga T; Mezzano D Semin Thromb Hemost; 2008 Oct; 34(7):654-62. PubMed ID: 19085766 [TBL] [Abstract][Full Text] [Related]
14. The evolution and value of bleeding assessment tools. Rydz N; James PD J Thromb Haemost; 2012 Nov; 10(11):2223-9. PubMed ID: 22974079 [TBL] [Abstract][Full Text] [Related]
19. The role of molecular genetics in diagnosing von Willebrand disease. James P; Lillicrap D Semin Thromb Hemost; 2008 Sep; 34(6):502-8. PubMed ID: 19085649 [TBL] [Abstract][Full Text] [Related]
20. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease. Shihong I; Morris D; Konkle BA Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]